New drug-related administration to be reformed

The Korea Food and Drug Administration is contemplating a series of new measures designed to ameliorate new drugs-related regulations, said Lee Hee-sung, director-general of Drug Safety Division of the KFDA, in a report released by the Korea Health Industry Development Institute. He further noted that:

- More detailed screening procedures and guidelines will be renovated for new pharmaceutic...